📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Systematic review and meta-analysis of anakinra, sarilumab, siltuximab and tocilizumab for COVID-19. (2021)

First Author: Khan FA

Attributed to: The UK Interstitial Lung Disease Long-COVID19 study (UKILD-Long COVID): understanding the burden of Interstitial Lung Disease in Long COVID. funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2020-215266

PubMed Identifier: 33579777

Publication URI: http://europepmc.org/abstract/MED/33579777

Type: Journal Article/Review

Volume: 76

Parent Publication: Thorax

Issue: 9

ISSN: 0040-6376